| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |